The JSE was stronger on Wednesday alongside European markets as developments in the search for a coronavirus vaccine supported risk appetite.

News that an experimental Covid-19 vaccine trial by US biotech company Moderna has shown immune response in all 45 volunteer patients, lifted market sentiment amid concerns about the rising number of Covid-19 cases...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.